Muscle Protein Synthesis
| Category | Biology |
|---|---|
| Also known as | MPS, Myofibrillar Protein Synthesis, Skeletal Muscle Anabolism |
| Last updated | 2026-04-14 |
| Reading time | 4 min read |
| Tags | musclemtorleucineanabolichypertrophyskeletal-muscle |
Overview
Skeletal muscle is in constant turnover. Every day, adult muscle synthesizes and degrades roughly 1–2% of its total protein mass, and the net balance between these two rates determines whether muscle grows, maintains, or wastes. Muscle protein synthesis (MPS) refers specifically to the anabolic side of that ledger — the translation of mRNA into new contractile and structural proteins such as myosin heavy chain, actin, titin, and tropomyosin.
MPS is exquisitely sensitive to three inputs: the supply of essential amino acids (especially leucine), mechanical loading, and a permissive hormonal background involving insulin, testosterone, growth hormone, and IGF-1. Peptides that raise growth hormone pulsatility — Sermorelin, CJC-1295, Ipamorelin, Tesamorelin, MK-677 — or that supply IGF-1 directly like IGF-1 LR3, are commonly explored for their capacity to bias this balance toward synthesis.
How It Works
The mTORC1 hub. The master regulator of MPS is mechanistic target of rapamycin complex 1. When activated, mTORC1 phosphorylates two key translational effectors: S6K1 (which boosts ribosome biogenesis and translation elongation) and 4E-BP1 (whose phosphorylation releases eIF4E, permitting cap-dependent translation initiation). Both effects increase the throughput of ribosomes producing new muscle protein.
Leucine sensing. Of all twenty amino acids, leucine is the signaling trigger. Cytosolic leucine is detected by sestrin2, which in turn releases GATOR2 to activate the Rag GTPases that recruit mTORC1 to the lysosomal surface. Once lysosomally docked, mTORC1 encounters Rheb — the GTPase that directly switches it on.
Insulin and IGF-1. Mechanical load drives MPS, but it does so most efficiently when insulin and IGF-1 are also present. Through their shared PI3K → Akt → TSC2 pathway (the same pathway detailed in insulin signaling), these hormones inhibit TSC2 and allow Rheb to remain in its active, GTP-bound state. This hormonal permission gates the leucine signal.
Mechanical loading. Resistance exercise generates mechanical stress transduced through focal adhesion kinase, phosphatidic acid accumulation in the sarcoplasmic reticulum, and Piezo1 channel activation. These mechanotransduction signals converge on mTORC1 independently of amino acids, which is why training amplifies the response to dietary protein.
The Anabolic Window
After a protein-containing meal or resistance training bout, fractional synthetic rate in human vastus lateralis rises sharply and remains elevated for three to six hours before returning to baseline. This post-prandial surge follows a dose-response with a practical ceiling near 0.4 g protein per kg body mass per meal, or roughly 2.5–3 g of leucine. Higher doses produce diminishing returns — a phenomenon sometimes called the "muscle full" effect.
Breakdown and Net Balance
MPS operates in counterpoint with muscle protein breakdown (MPB), largely executed by the ubiquitin-proteasome system and autophagy. Net protein accretion occurs only when MPS exceeds MPB over a 24-hour window. Insulin and feeding suppress MPB modestly, while the main lever for growth remains pushing MPS upward. Catabolic states — glucocorticoid excess, bed rest, sepsis, and aging — shift the ratio in the opposite direction.
Anabolic Resistance with Age
Older adults require roughly twice the leucine dose to mount an MPS response equivalent to that of younger adults. This "anabolic resistance" reflects reduced muscle perfusion, lower mTORC1 sensitivity, and impaired satellite cell activation. Strategies that amplify the anabolic signal — resistance training, leucine-rich feeding patterns, and growth hormone axis support through peptides like Ipamorelin or CJC-1295 — can partially rescue the response.
Relationship to Hypertrophy
Over weeks of progressive overload, repeated bouts of elevated MPS yield measurable gains in myofibrillar protein content. Satellite cells donate their nuclei to growing fibers to sustain the enlarged cytoplasmic volume, a process covered in satellite cell activation. Peptides such as BPC-157 are studied for their supportive role in tendon and muscle repair during heavy training cycles.
Related entries
- Amino Acid Metabolism— Amino acid metabolism encompasses the synthesis, interconversion, and degradation of amino acids — the building blocks of all peptides and proteins — including transamination reactions, the urea cycle, and the pathways that connect amino acids to energy metabolism.
- Insulin Signaling— The molecular cascade initiated by insulin binding to its receptor, driving glucose uptake, glycogen synthesis, and metabolic regulation across multiple tissues.
- Protein Synthesis— Protein synthesis is the fundamental cellular process by which genetic information encoded in mRNA is translated by ribosomes into functional polypeptide chains, governed by signaling pathways including mTOR.
- Satellite Cell Activation— How quiescent muscle stem cells activate, proliferate, and differentiate to repair damaged muscle fibers and support hypertrophy.
- BPC-157— A 15-amino-acid peptide derived from human gastric juice protein BPC, extensively studied in animal models for its role in tissue repair, cytoprotection, and wound healing acceleration.
- CJC-1295— A synthetic analog of growth hormone releasing hormone (GHRH) available in two forms — with and without Drug Affinity Complex (DAC) — studied for sustained stimulation of pituitary GH secretion.
- IGF-1 LR3— A synthetic, extended-half-life variant of insulin-like growth factor 1 (IGF-1) with an arginine substitution at position 3 and a 13-amino-acid N-terminal extension, engineered for reduced IGF binding protein affinity and prolonged biological activity.
- Ipamorelin— A selective growth hormone secretagogue pentapeptide that stimulates GH release from the pituitary with minimal effects on cortisol, prolactin, and appetite compared to other GHRPs.
- MK-677— MK-677 (Ibutamoren) is an orally bioavailable non-peptide ghrelin receptor agonist that stimulates growth hormone and IGF-1 release.
- Sermorelin— A 29-amino-acid synthetic analog of growth hormone releasing hormone (GHRH) with a history of FDA approval, studied for age-related GH decline, pediatric growth deficiency, and anti-aging applications.
- Tesamorelin— A synthetic growth hormone-releasing hormone (GHRH) analog approved by the FDA for reduction of excess abdominal fat in HIV-associated lipodystrophy, also studied for cognitive and metabolic applications.